의료 분야 5G 시장 규모, 점유율 및 동향 분석 보고서 : 구성 요소별, 용도별, 최종 용도별, 지역별 및 부문별 전망(2026-2033년)

The global 5G in healthcare market size was valued at USD 83.0 billion in 2025 and is projected to grow from USD 116.7 billion in 2026 to USD 1,260.9 billion in 2033, at a CAGR of 40.5% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. The global market is driven by the increasing adoption of robotic surgery and telehealth, alongside advancements in telecommunication and 5G technology.

The deployment of 5G-based wearable medical devices, the ability of 5G to transfer massive patient data files quickly, and the availability of affordable sensors are fueling market growth. In addition, partnerships between governments and key market players to deploy 5G in healthcare are propelling this growth. For example, in March 2024, Thailand and Huawei partnered to establish ASEAN's first 5G-enabled "smart hospital," aiming to enhance healthcare delivery through the integration of 5G technology, artificial intelligence, multi-access edge computing, and a hybrid cloud system.

5G technology is revolutionizing the healthcare sector by enhancing various applications such as telemedicine, augmented reality (AR), and remote patient monitoring (RPM). It enables high-speed, low-latency data transfers, which are crucial for real-time consultations, high-resolution medical imaging, and seamless communication between medical staff and patients. In practice, 5G supports advanced use cases like connected ambulances for real-time patient data sharing, AR tools for improved surgical procedures, and high-capacity networks that handle large volumes of medical data efficiently. The technology's improved reliability, security, and performance are key factors driving its adoption and transforming healthcare delivery.

Moreover, the recent pandemics and epidemic such as Covid-19 and mpox has driven a shift towards digital transformation of the healthcare system. It focuses on adopting virtual services, which increase network bandwidth and reliable data connectivity.

In the healthcare sector, cellular technology is poised to enhance the speed, coverage, and responsiveness of wireless networks. The increasing demand for faster and more reliable data transmission is expected to drive market growth. 5G technology will support a new healthcare ecosystem by providing the connectivity needed to efficiently and cost-effectively meet the needs of both patients and providers. It will serve as the backbone for IoT infrastructure, low-bitrate devices, supporting clinical wearables, remote sensors, and low-energy health monitoring systems.

Technological advancements are driving the market, with players establishing new 5G-powered healthcare facilities to revolutionize patient care. For instance, the GE Healthcare's first 5G Innovation Lab was opened in Bengaluru, India. This facility utilizes 5G's high bandwidth, data speeds, low latency, and reliable connectivity to enhance the patient care continuum, including therapy, diagnosis, and prognosis. The lab positions GE Healthcare at the forefront of these advancements, extending advanced healthcare solutions to rural and suburban areas.

Global 5G In Healthcare Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global 5G in healthcare market report based on component, application, end use, and region:

• Component Mode Outlook (Revenue, USD Billion, 2021 - 2033)

Hardware

Service

• Application Outlook (Revenue, USD Billion, 2021 - 2033)

Remote Patient Monitoring

Connected Medical Devices

AR/VR

Connected Ambulance

Asset Tracking

• End use Outlook (Revenue, USD Billion, 2021 - 2033)

Healthcare Providers

Healthcare Payers

Other End Users

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

North America

• U.S.
• Canada
• Mexico

Europe

• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• Thailand

Latin America

• Brazil
• Argentina

Middle East and Africa

• South Africa
• Saudi Arabia
• UAE
• Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Component
  • 1.1.2. Application
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Component outlook
  • 2.2.2. Application
  • 2.2.3. End Use
  • 2.2.4. Distribution Channel
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. 5G In Healthcare Market Variables, Trends & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market driver analysis
  • 3.1.2. Market restraint analysis
  • 3.1.3. Market Opportunity Analysis
• 3.2. 5G In Healthcare Market Analysis Tools
  • 3.2.1. Industry Analysis - Porter's Five Forces
    • 3.2.1.1. Supplier power
    • 3.2.1.2. Buyer power
    • 3.2.1.3. Substitution threat
    • 3.2.1.4. Threat of new entrant
    • 3.2.1.5. Competitive rivalry
  • 3.2.2. PESTEL Analysis
    • 3.2.2.1. Political landscape
    • 3.2.2.2. Economic landscape
    • 3.2.2.3. Social landscape
    • 3.2.2.4. Technological landscape
    • 3.2.2.5. Environmental landscape
    • 3.2.2.6. Legal landscape
  • 3.2.3. COVID-19 Impact Analysis

Chapter 4. 5G In Healthcare Market: Component Estimates & Trend Analysis

• 4.1. Component Type Market Share, 2025 & 2033
• 4.2. Segment Dashboard
• 4.3. Global 5G In Healthcare Market by Component Type Outlook
• 4.4. Hardware
  • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Billion)
• 4.5. Service
  • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Billion)

Chapter 5. 5G In Healthcare Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2025 & 2033
• 5.2. Segment Dashboard
• 5.3. Global 5G In Healthcare Market by Application Outlook
• 5.4. Remote Patient Monitoring
  • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Billion)
• 5.5. Connected Medical Devices
  • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Billion)
• 5.6. AR/VR
  • 5.6.1. Market estimates and forecast 2021 to 2033 (USD Billion)
• 5.7. Connected Ambulance
  • 5.7.1. Market estimates and forecast 2021 to 2033 (USD Billion)
• 5.8. Asset Tracking
  • 5.8.1. Market estimates and forecast 2021 to 2033 (USD Billion)

Chapter 6. 5G In Healthcare Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2025 & 2033
• 6.2. Segment Dashboard
• 6.3. Global 5G In Healthcare Market by End Use Outlook
• 6.4. Healthcare Providers
  • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Billion)
• 6.5. Healthcare Payers
  • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Billion)
• 6.6. Other End Users
  • 6.6.1. Market estimates and forecast 2021 to 2033 (USD Billion)

Chapter 7. 5G In Healthcare Market: Regional Estimates & Trend Analysis, By Product, By Application, By End Use

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Billion)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Billion)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Billion)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Billion)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market share/position analysis, 2025
• 8.4. Company Profiles
  • 8.4.1. AT&T
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Technology Type benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Verizon
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Technology Type benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. China Mobile International Limited
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Technology Type benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Quectel
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Technology Type benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Telit
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Technology Type benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Telus
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Technology Type benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Huawei Technologies Co., Ltd.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Technology Type benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Cisco System Inc.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Technology Type benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Orange
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Technology Type benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. NEC Corporation
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Technology Type benchmarking
    • 8.4.10.4. Strategic initiatives